ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Long-term efficacy of microwave ablation in the treatment of subcapsular hepatocellular carcinomas of ≤3 cm in diameter: a multicenter, propensity score-matched study

Yao, Jundong; Liu, Binbin; Wang, Xiaohui; Yu, Jie; Cheng, Zhigang; Han, Zhiyu; Liu, Fangyi; Zheng, Rongqin; Cheng, Wen; Qiang Wei; Yu, Songyuan; Li, Kai; Chen, Peng; Luo, Yanchun; Yu, Xiaoling*; Liang, Ping*哈尔滨医科大学; 郑州大学; 中山大学; 1; 5
International Journal of Hyperthermia2022-12-31DOI: 10.1080/02656736.2021.2023228
2被引2阅读
引用收藏
分享

摘要

Objective To compare the long-term efficacy of microwave ablation (MWA) for subcapsular and non-subcapsular hepatocellular carcinomas (HCCs) using propensity score matching (PSM). Materials and methods Using a multicenter database, we enrolled 430 patients (347 men, 83 women; age range, 15-71 years) with HCCs who received percutaneous ultrasound-guided MWA, between January 2012 and December 2018. The patients were grouped as follows, based on whether the tumor was adjacent to the capsule: subcapsular group (n = 142) and non-subcapsular group (n = 142). To evaluate the correlation between subcapsular position and efficacy of MWA, a Cox proportional hazards model was used to calculate disease-free survival (DFS) and overall survival (OS) based on PSM data. Results In total, 142 pairs of patients were matched. In the PSM cohort, the 1-year, 3-year, and 5-year DFS rates of the subcapsular and non-subcapsular groups were 84%, 61%, and 47%, respectively, and 85%, 67%, and 58%, respectively, while the 1-year, 3-year, and 5-year OS rates were 98%, 90%, and 84%, respectively, and 98%, 90%, and 88%, respectively. In the PSM cohort, subcapsular position was not an independent risk factor for DFS (hazard ratio [HR] = 1.291, p = 0.196) or OS (HR = 0.926, p = 0.866). Additionally, there were no significant differences in the incidence of local tumor progression, major complications, technical success rate, number of puncture needles, and postoperative hospital stay between the two groups (p > 0.05). Conclusion There were no significant differences in DFS, OS, incidence of local tumor progression, and major complications between patients with subcapsular and non-subcapsular HCCs treated with MWA.

学科与关键词

关键词
Microwave ablationsubcapsularhepatocellular carcinomapropensity score matching
相关
加载中…
  • Long-term efficacy and safety of microwave ablation for hepatocellular carcinoma adjacent to the gallbladder with a diameter ≤ 5 cm: a multicenter, propensity score matching study
    Li, Lijuan; Yao, Jundong; Yan, Xizi; Qi, Xiaoguang; Liang, Ping; Han, Zhiyu; Liu, Fangyi; Cheng, Zhigang; Luo, Yanchun; Zheng, Rongqin; Cheng, Wen; Wei, Qiang; Yu, Songyuan; Yu, Jie*; Yu, Xiaoling*International Journal of Hyperthermia, 2023, 40(1): 2248425.
  • Period-Dependent Survival Benefit of Percutaneous Microwave Ablation for Hepatocellular Carcinoma: A 12-Year Real-World, Multicentric Experience
    Yu, Jie; Cheng, Zhi-Gang; Han, Zhi-Yu; Liu, Fang-Yi; Zheng, Rong-Qin; Cheng, Wen; Wei, Qiang; Yu, Song-Yuan; Li, Qin-ying; He, Guang-zhi; Luo, Yan-chun; Yu, Xiao-Ling; Liang, Ping*Liver Cancer, 2022, 11(4): 341-353.被引 9
  • Learning curve of microwave ablation for liver cancers
    Dou, Jianping; Yu, Jie; Cheng, Wen; Wei, Qiang; Luo, Yanchun; Han, Zhiyu; Cheng, Zhigang; Liu, Fangyi; Yu, Xiaoling; Liang, Ping*EUROPEAN JOURNAL OF RADIOLOGY, 2023, 158: 110613.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
International Journal of Hyperthermia
发表日期
2022-12-31
卷期
第 39 卷, 第 1 期
页码
209-216
DOI
10.1080/02656736.2021.2023228
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Science and Technology Major Project of the Ministry of Science and Technology of China [2017ZX10203204-008]; National Natural Science Foundation of China [82172027]

作者

  • Y

    Yao, Jundong (第一作者)

    5 · chinese peoples liberat army gen hosp

  • L

    Liu, Binbin

    henan univ

查看全部 16 位作者收起作者
  • W

    Wang, Xiaohui

    1 · zhengzhou univ

  • Y

    Yu, Jie

    5 · chinese peoples liberat army gen hosp

  • C

    Cheng, Zhigang

    5 · chinese peoples liberat army gen hosp

  • H

    Han, Zhiyu

    5 · chinese peoples liberat army gen hosp

  • L

    Liu, Fangyi

    5 · chinese peoples liberat army gen hosp

  • Z

    Zheng, Rongqin

    sun yat sen univ

  • C

    Cheng, Wen

    harbin med univ

  • Q

    Qiang Wei

    2 · nanjing univ chinese med

  • Y

    Yu, Songyuan

    wuhan univ sci & technol

  • L

    Li, Kai

  • C

    Chen, Peng

  • L

    Luo, Yanchun

    5 · chinese peoples liberat army gen hosp

  • Y

    Yu, Xiaoling (通讯)

    5 · chinese peoples liberat army gen hosp

  • L

    Liang, Ping (通讯)

    5 · chinese peoples liberat army gen hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417